Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide

Mary Jane Elliott, Kathleen M. Murphy, Lolita Stribinskiene, Velvizhi Ranganathan, Eric Sturges, Monica L. Farnsworth, Richard B. Lock

Research output: Contribution to journalArticle

Abstract

Defective apoptotic mechanisms are considered to play a role in both the development of malignancy and resistance to chemotherapeutic drugs. The Bcl- 2 family of proteins regulate the cellular commitment to survive or die when challenged with various apoptotic stimuli. Purpose: The purpose of this study was to identify the point at which Bcl-2 interrupts the apoptotic cascade initiated following exposure of human tumor cells to etoposide. Methods: A stable Bcl-2-expressing HeLa-transfected clonal cell line, along with its control-vector-transfected counterpart, were utilized in this study. Following etoposide exposure, cells were examined for cell cycle arrest, formation of hyperdiploid cells, apoptotic DNA degradation, loss of plasma membrane integrity, levels of expression of members of the Bcl-2 protein family, caspase activation, degradation of poly(ADP-ribose) polymerase and movement of Bax from cytosol to cellular membrane fractions. Results: Caspase activation, poly(ADP-ribose) polymerase degradation and Bax membrane insertion were initiated rapidly following etoposide removal, concomitantly with cell cycle arrest. Whereas Bcl-2 had no effect on etoposide-induced cell arrest, it interrupted all aspects of apoptosis, including activation of caspases, poly(ADP-ribose) polymerase degradation, DNA fragmentation and loss of plasma membrane integrity. Surprisingly, Bcl-2 also blocked Bax membrane insertion. In addition, Bcl-2 also prevented the increase in cellular levels of Bak, Bax and Bcl-X(L), along with degradation of actin and Bax. However, inhibition of etoposide-induced apoptosis by Bcl-2 resulted in the accumulation of giant, multinucleated cells that eventually lost the ability to exclude trypan blue without apoptotic morphology or DNA degradation. Conclusions: These results indicate that biochemical apoptotic processes-are initiated concomitant with etoposide-induced cell cycle arrest and are interrupted by Bcl-2 overexpression. However, the aberrant mitotic events induced by etoposide are sufficient to kill these cells even in the absence of apoptosis.

Original languageEnglish (US)
Pages (from-to)1-11
Number of pages11
JournalCancer Chemotherapy and Pharmacology
Volume44
Issue number1
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Etoposide
Cell Cycle Checkpoints
Tumors
Epithelial Cells
Cells
Degradation
Poly(ADP-ribose) Polymerases
Caspases
Neoplasms
Chemical activation
DNA Fragmentation
Cell membranes
Apoptosis
Membranes
DNA
Biochemical Phenomena
Cell Membrane
Polyploidy
Trypan Blue
Giant Cells

Keywords

  • Apoptosis
  • Bax
  • Bcl-2
  • Cell cycle check-points
  • Etoposide

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this

Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide. / Elliott, Mary Jane; Murphy, Kathleen M.; Stribinskiene, Lolita; Ranganathan, Velvizhi; Sturges, Eric; Farnsworth, Monica L.; Lock, Richard B.

In: Cancer Chemotherapy and Pharmacology, Vol. 44, No. 1, 1999, p. 1-11.

Research output: Contribution to journalArticle

Elliott, Mary Jane ; Murphy, Kathleen M. ; Stribinskiene, Lolita ; Ranganathan, Velvizhi ; Sturges, Eric ; Farnsworth, Monica L. ; Lock, Richard B. / Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide. In: Cancer Chemotherapy and Pharmacology. 1999 ; Vol. 44, No. 1. pp. 1-11.
@article{c15362d45b86479c956eb58fd873c49a,
title = "Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide",
abstract = "Defective apoptotic mechanisms are considered to play a role in both the development of malignancy and resistance to chemotherapeutic drugs. The Bcl- 2 family of proteins regulate the cellular commitment to survive or die when challenged with various apoptotic stimuli. Purpose: The purpose of this study was to identify the point at which Bcl-2 interrupts the apoptotic cascade initiated following exposure of human tumor cells to etoposide. Methods: A stable Bcl-2-expressing HeLa-transfected clonal cell line, along with its control-vector-transfected counterpart, were utilized in this study. Following etoposide exposure, cells were examined for cell cycle arrest, formation of hyperdiploid cells, apoptotic DNA degradation, loss of plasma membrane integrity, levels of expression of members of the Bcl-2 protein family, caspase activation, degradation of poly(ADP-ribose) polymerase and movement of Bax from cytosol to cellular membrane fractions. Results: Caspase activation, poly(ADP-ribose) polymerase degradation and Bax membrane insertion were initiated rapidly following etoposide removal, concomitantly with cell cycle arrest. Whereas Bcl-2 had no effect on etoposide-induced cell arrest, it interrupted all aspects of apoptosis, including activation of caspases, poly(ADP-ribose) polymerase degradation, DNA fragmentation and loss of plasma membrane integrity. Surprisingly, Bcl-2 also blocked Bax membrane insertion. In addition, Bcl-2 also prevented the increase in cellular levels of Bak, Bax and Bcl-X(L), along with degradation of actin and Bax. However, inhibition of etoposide-induced apoptosis by Bcl-2 resulted in the accumulation of giant, multinucleated cells that eventually lost the ability to exclude trypan blue without apoptotic morphology or DNA degradation. Conclusions: These results indicate that biochemical apoptotic processes-are initiated concomitant with etoposide-induced cell cycle arrest and are interrupted by Bcl-2 overexpression. However, the aberrant mitotic events induced by etoposide are sufficient to kill these cells even in the absence of apoptosis.",
keywords = "Apoptosis, Bax, Bcl-2, Cell cycle check-points, Etoposide",
author = "Elliott, {Mary Jane} and Murphy, {Kathleen M.} and Lolita Stribinskiene and Velvizhi Ranganathan and Eric Sturges and Farnsworth, {Monica L.} and Lock, {Richard B.}",
year = "1999",
doi = "10.1007/s002800050938",
language = "English (US)",
volume = "44",
pages = "1--11",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide

AU - Elliott, Mary Jane

AU - Murphy, Kathleen M.

AU - Stribinskiene, Lolita

AU - Ranganathan, Velvizhi

AU - Sturges, Eric

AU - Farnsworth, Monica L.

AU - Lock, Richard B.

PY - 1999

Y1 - 1999

N2 - Defective apoptotic mechanisms are considered to play a role in both the development of malignancy and resistance to chemotherapeutic drugs. The Bcl- 2 family of proteins regulate the cellular commitment to survive or die when challenged with various apoptotic stimuli. Purpose: The purpose of this study was to identify the point at which Bcl-2 interrupts the apoptotic cascade initiated following exposure of human tumor cells to etoposide. Methods: A stable Bcl-2-expressing HeLa-transfected clonal cell line, along with its control-vector-transfected counterpart, were utilized in this study. Following etoposide exposure, cells were examined for cell cycle arrest, formation of hyperdiploid cells, apoptotic DNA degradation, loss of plasma membrane integrity, levels of expression of members of the Bcl-2 protein family, caspase activation, degradation of poly(ADP-ribose) polymerase and movement of Bax from cytosol to cellular membrane fractions. Results: Caspase activation, poly(ADP-ribose) polymerase degradation and Bax membrane insertion were initiated rapidly following etoposide removal, concomitantly with cell cycle arrest. Whereas Bcl-2 had no effect on etoposide-induced cell arrest, it interrupted all aspects of apoptosis, including activation of caspases, poly(ADP-ribose) polymerase degradation, DNA fragmentation and loss of plasma membrane integrity. Surprisingly, Bcl-2 also blocked Bax membrane insertion. In addition, Bcl-2 also prevented the increase in cellular levels of Bak, Bax and Bcl-X(L), along with degradation of actin and Bax. However, inhibition of etoposide-induced apoptosis by Bcl-2 resulted in the accumulation of giant, multinucleated cells that eventually lost the ability to exclude trypan blue without apoptotic morphology or DNA degradation. Conclusions: These results indicate that biochemical apoptotic processes-are initiated concomitant with etoposide-induced cell cycle arrest and are interrupted by Bcl-2 overexpression. However, the aberrant mitotic events induced by etoposide are sufficient to kill these cells even in the absence of apoptosis.

AB - Defective apoptotic mechanisms are considered to play a role in both the development of malignancy and resistance to chemotherapeutic drugs. The Bcl- 2 family of proteins regulate the cellular commitment to survive or die when challenged with various apoptotic stimuli. Purpose: The purpose of this study was to identify the point at which Bcl-2 interrupts the apoptotic cascade initiated following exposure of human tumor cells to etoposide. Methods: A stable Bcl-2-expressing HeLa-transfected clonal cell line, along with its control-vector-transfected counterpart, were utilized in this study. Following etoposide exposure, cells were examined for cell cycle arrest, formation of hyperdiploid cells, apoptotic DNA degradation, loss of plasma membrane integrity, levels of expression of members of the Bcl-2 protein family, caspase activation, degradation of poly(ADP-ribose) polymerase and movement of Bax from cytosol to cellular membrane fractions. Results: Caspase activation, poly(ADP-ribose) polymerase degradation and Bax membrane insertion were initiated rapidly following etoposide removal, concomitantly with cell cycle arrest. Whereas Bcl-2 had no effect on etoposide-induced cell arrest, it interrupted all aspects of apoptosis, including activation of caspases, poly(ADP-ribose) polymerase degradation, DNA fragmentation and loss of plasma membrane integrity. Surprisingly, Bcl-2 also blocked Bax membrane insertion. In addition, Bcl-2 also prevented the increase in cellular levels of Bak, Bax and Bcl-X(L), along with degradation of actin and Bax. However, inhibition of etoposide-induced apoptosis by Bcl-2 resulted in the accumulation of giant, multinucleated cells that eventually lost the ability to exclude trypan blue without apoptotic morphology or DNA degradation. Conclusions: These results indicate that biochemical apoptotic processes-are initiated concomitant with etoposide-induced cell cycle arrest and are interrupted by Bcl-2 overexpression. However, the aberrant mitotic events induced by etoposide are sufficient to kill these cells even in the absence of apoptosis.

KW - Apoptosis

KW - Bax

KW - Bcl-2

KW - Cell cycle check-points

KW - Etoposide

UR - http://www.scopus.com/inward/record.url?scp=0033028618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033028618&partnerID=8YFLogxK

U2 - 10.1007/s002800050938

DO - 10.1007/s002800050938

M3 - Article

VL - 44

SP - 1

EP - 11

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 1

ER -